Skip to main content

Advertisement

SpringerLink
Log in

Do all drugs and treatments for rheumatoid arthritis have the same efficacy?

  • Viewpoint
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Donahue KE et al. (2008) Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med 148: 124–134

    Article  Google Scholar 

  2. Boers M et al. (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350: 309–318

    Article  CAS  Google Scholar 

  3. Landewé RB et al. (2002) COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 46: 347–356

    Article  Google Scholar 

  4. Grigor C et al. (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364: 263–269

    Article  Google Scholar 

  5. Grigor C et al. (2006) 5-year follow-up of the trial of Tight Control for Rheumatoid Arthritis (TICORA) study. Arthritis Rheum 54: S310

    Google Scholar 

  6. Verstappen SM et al. (2007) Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66: 1443–1449

    Article  CAS  Google Scholar 

  7. Goekoop-Ruiterman YP et al. (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52: 3381–3390

    Article  CAS  Google Scholar 

  8. van der Bijl AE et al. (2007) Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis Rheum 56: 2129–2134

    Article  CAS  Google Scholar 

  9. Goekoop-Ruiterman YP et al. (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146: 406–415

    Article  Google Scholar 

  10. van Dongen H et al. (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 56: 1424–1432

    Article  CAS  Google Scholar 

  11. Gonzalez A et al. (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56: 3583–3587

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Division of Rheumatology, Cedars–Sinai Medical Center, 8700 Beverly Boulevard, Becker B-131, Los Angeles, CA 90048, USA michael.weisman@cshs.org

Authors and Affiliations

  1. MH Weisman is the Director of the Division of Rheumatology, Cedars–Sinai Medical Center, Los Angeles, CA, USA.,

    Michael H Weisman

Authors
  1. Michael H Weisman
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

MH Weisman has received research grants from the following companies: Abbott, Amgen, Bristol-Myers Squibb, Centocor, Genentech, Human Genome Sciences, UCB, Wyeth and XDx Expression Diagnostics. MH Weisman is a consultant/advisor/member of Data-Safety Monitoring Board for the following companies: Abbott, Amgen, Array, Biogen, Centocor, Elan, Genentech, Human Genome Sciences, Merck, TAP, UCB and Wyeth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weisman, M. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?. Nat Rev Rheumatol 4, 298–299 (2008). https://doi.org/10.1038/ncprheum0806

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0806

  • Springer Nature Limited

This article is cited by

Search

Navigation